Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate and dexamethasone as adjuvants to ropivacaine for supraclavicular upper limb block
IRCT20180325039148N3Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine, magnesium sulfate and dexamethasone in arm injury, hand injury, Wrist disorder and 1 more (3 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Onset of sensory block, Onset of motor block and 4 more. Started Jun 2019; status: completed.
02
Drugs
ropivacainemagnesium sulfatedexamethasone
03
Conditions
arm injuryhand injuryWrist disorderForearm injuries
Beyond the preview
Go deeper on IRCT20180325039148N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180325039148N3.